Evidence map›Paper›PMID 26739278›Full record

ArticleVision research2016

A proto-object based saliency model in three-dimensional space.

Brian Hu, Ralinkae Kane-Jackson, Ernst Niebur

Abstract read
In one paragraph

Article in Vision research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Proto-Object Based Saliency Model With Texture Detection Channel.Frontiers in computational neuroscience · 2020
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Brian HuZanvyl Krieger Mind/Brain Institute, Johns Hopkins University, Baltimore, MD 21218, United States; Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD 21218, United States. Electronic address: bhu6@jhmi.edu.
Ralinkae Kane-JacksonZanvyl Krieger Mind/Brain Institute, Johns Hopkins University, Baltimore, MD 21218, United States. Electronic address: rkanejac@terpmail.umd.edu.
Ernst NieburZanvyl Krieger Mind/Brain Institute, Johns Hopkins University, Baltimore, MD 21218, United States; Department of Neuroscience, Johns Hopkins University, Baltimore, MD 21218, United States. Electronic address: niebur@jhu.edu.

Funding

CRCNS-Attentional Selection and Perceptual OrganizationR01EY016281 · NEI · JOHNS HOPKINS UNIVERSITY · PI NIEBUR, ERNST · 2004 to 2012
$2.9M
NEI NIH HHS R01 EY016281NEI NIH HHS R01EY016281-02
6 · The paper itself

Abstract

Most models of visual saliency operate on two-dimensional images, using elementary image features such as intensity, color, or orientation. The human visual system, however, needs to function in complex three-dimensional environments, where depth information is often available and may be used to guide the bottom-up attentional selection process. In this report we extend a model of proto-object based saliency to include depth information and evaluate its performance on three separate three-dimensional eye tracking datasets. Our results show that the additional depth information provides a small, but statistically significant, improvement in the model's ability to predict perceptual saliency (eye fixations) in natural scenes. The computational mechanisms of our model have direct neural correlates, and our results provide further evidence that proto-objects help to establish perceptual organization of the scene.

Indexed as

Models, TheoreticalAlgorithmsAttentionDepth PerceptionEye MovementsFixation, OcularHumansPhotic StimulationDepth saliencyGestaltProto-objectSaliency mapVisual attention

Identifiers

PMID26739278
PMCPMC4749459

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.